Congenital disorders of neuromuscular transmission.
Pathology underlying congenital forms of myasthenia gravis has been delineated through microscopic and electrophysiologic studies over the past 15 years. Differentiation from the immune-mediated disorder is crucial because therapy appropriate for acquired myasthenia may be harmful to patients with congenital disease.
Kaminski
H J
HJ
Department of Neurology, Case Western Reserve University School of Medicine.
Ruff
R L
RL
D000200:Action Potentials; D000906:Antibodies / Q000097:blood; D001706:Biopsy; D003937:Diagnosis, Differential; D004576:Electromyography; D006801:Humans; D009045:Motor Endplate; D009157:Myasthenia Gravis / Q000145:classification / Q000151:congenital* / Q000175:diagnosis; D011950:Receptors, Cholinergic / Q000276:immunology; D012017:Referral and Consultation; D009435:Synaptic Transmission
D000906:Antibodies; D011950:Receptors, Cholinergic